| Mrs Chloe L Elrod, MSN, FNP-C | |
|
3368 Highway 280 Ste 130, Alexander City, AL 35010-3375 | |
| (256) 234-2644 | |
| Not Available |
| Full Name | Mrs Chloe L Elrod |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 3368 Highway 280 Ste 130, Alexander City, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114442530 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 1-161159 (Alabama) | Primary |
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
Acura Pharmaceuticals, Inc. today announced that it has been informed by King Pharmaceuticals Research and Development Inc. (King) that King's New Drug Application (NDA) for ACUROX® (oxycodone HCl) Tablets was accepted for filing by the US Food and Drug Administration (FDA) with a Priority review classification and a Prescription Drug User Fee Act (PDUFA) date of June 17, 2011.
Forty years after the birth of Louise Brown, the world's first test-tube baby, an international committee monitoring progress in assisted reproduction reports today that the global total of babies born as a result of IVF and other advanced fertility treatments is "more than 8 million"
Geron Corporation announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the clinical hold placed on Geron's Investigational New Drug (IND) application has been lifted and the company's Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may proceed.
A research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University, has developed a nanoplatform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma.
The non-profit research and development organization Drugs for Neglected Diseases initiative has released results of a study in South Africa that will make it easier for healthcare workers to treat children living with HIV who are co-infected with tuberculosis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Chloe L Elrod, MSN, FNP-C 14104 Retreat Ln, Birmingham, AL 35242-7521 Ph: (601) 927-9889 | Mrs Chloe L Elrod, MSN, FNP-C 3368 Highway 280 Ste 130, Alexander City, AL 35010-3375 Ph: (256) 234-2644 |
News Archive
Acura Pharmaceuticals, Inc. today announced that it has been informed by King Pharmaceuticals Research and Development Inc. (King) that King's New Drug Application (NDA) for ACUROX® (oxycodone HCl) Tablets was accepted for filing by the US Food and Drug Administration (FDA) with a Priority review classification and a Prescription Drug User Fee Act (PDUFA) date of June 17, 2011.
Forty years after the birth of Louise Brown, the world's first test-tube baby, an international committee monitoring progress in assisted reproduction reports today that the global total of babies born as a result of IVF and other advanced fertility treatments is "more than 8 million"
Geron Corporation announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the clinical hold placed on Geron's Investigational New Drug (IND) application has been lifted and the company's Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may proceed.
A research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University, has developed a nanoplatform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma.
The non-profit research and development organization Drugs for Neglected Diseases initiative has released results of a study in South Africa that will make it easier for healthcare workers to treat children living with HIV who are co-infected with tuberculosis.
› Verified 7 days ago
Sheena C Hunter, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 44 Aliant Pkwy, Alexander City, AL 35010 Phone: 256-234-4131 Fax: 256-234-9979 | |
Maria Luisa Coxey, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3316 Highway 280, Alexander City, AL 35010 Phone: 256-329-7100 | |
Mrs. Kayla Kizziah Tidwell, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3316 Highway 280, Alexander City, AL 35010 Phone: 256-329-7100 | |
Amanda Hardy, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1120 Airport Dr, Alexander City, AL 35010 Phone: 256-212-9300 | |
Emily Shelby, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2508 Highway 280, Alexander City, AL 35010 Phone: 256-414-3013 | |
Jason Paul Jones, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3316 Highway 280, Alexander City, AL 35010 Phone: 256-329-7100 |